Gill Holdsworth

3PUBLICATIONS
5CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)Biomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 06, 2025
Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies.

Timothy J Dreyer, Jacob A C Keen, Leah M Wells

|Mar 30, 2021
Sclerostin Downregulation Globally by Naturally Occurring Genetic Variants, or Locally in Atherosclerotic Plaques, Does Not Associate With Cardiovascular Events in Humans.

Gill Holdsworth, James R Staley, Peter Hall

Pageof 1